Wyeth posted slightly lower first-quarter earnings on Tuesday, hurt by the recent launch of generic forms of its Protonix ulcer drug, but surprisingly strong sales of other medicines enabled the company to beat Wall Street profit forecasts.
From: news.yahoo.com
Wyeth profit hurt by generics
Posted by Ruslan Abuzant at 8:39 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment